Proteon Therapeutics, Inc. Presents New Data on PRT-201 at the Annual Meeting of the American Society of Nephrology in Philadelphia

WALTHAM, Mass.--(BUSINESS WIRE)--Proteon Therapeutics is presenting new data today on a study of PRT-201 in an animal model of vascular access. The abstract, entitled “Local Application of Recombinant Human Type 1 Pancreatic Elastase (PRT-201) to an AVF Increases AVF Blood Flow in a Rabbit Model,” is part of a poster session at Renal Week 2008 corresponding to the 41st annual meeting and scientific exposition of the American Society of Nephrology.